For Quick Alerts
For Daily Alerts

Sun Pharma Reports a Rise in Q4 Profit at Rs 1,376 Crore


Sun Pharmaceutical Industries Ltd.'s reported a 6.93 percent rise in consolidated profit to Rs 1,375.62 crore for the fourth quarter of the financial year 2017-18. It was Rs 1,223.71 crore in the same period of the previous year.

Sun Pharma Reports a Rise in Q4 Profit at Rs 1,376 Crore

In a regulatory filing, it reported a revenue from operations at Rs 6,997.10 crore, which is 2.23 percent lower than Rs 7,136.96 crore in the January-March 2017 period. Its year-on-year (YoY) net sales had also fallen by 2.2 percent to Rs 6,980 crore.

It was observed that its profit increased from a one-time tax gain of Rs 259 crore during the quarter under review.

The company's total revenue from operations was higher at Rs 2,283.18 crore against Rs 2,015.02 crore in 2017.

Sun Pharma's YoY operating income rose 8.8 percent to Rs 1,683.5 crore, while margin narrowed down to 24.1 percent from 24.8 percent.

Its net profit on standalone basis rose by 83.29 percent to Rs 176.26 crore in the fourth quarter 2018 period compared to Rs 96.16 crore in the same period last year.

Shares of Sun Pharma closed 1.32 percent (Rs 6.10) higher at Rs 468.95 on NSE (National Stock Exchange).

Read more about: sun pharma
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more